Clinical trial
Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor…
NCT00168090 · CSL Behring, Industry · Completed
Key facts
| NCT number | NCT00168090 |
|---|---|
| Title | Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) |
| Official title | Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex (Humate-P®) Using Individualized Dosing in Pediatric and Adult Surgical Subjects With Von Willebrand's Disease. |
| Lead sponsor | CSL Behring, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Von Willebrand Disease, Blood Coagulation Disorders, Blood Platelet Disorders, Hematologic Disease |
| Intervention type | Drug |
| Interventions | Blood coagulation Factor VIII and vWF, human |
| Enrollment | 30 |
| Start date | Oct 1, 2001 |
| Completion | May 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Feb 11, 2011 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: